Similar articles

• Pharmacologic Issues in treating hypertension in CKD.

  Sica DA. Sica DA. Adv Chronic Kidney Dis. 2011 Jan;18(1):42-7. doi: 10.1053/j.ackd.2010.11.003. Adv Chronic Kidney Dis. 2011. PMID: 21224029 Review.
• Arterial hypertension and proteinuria in pediatric chronic kidney disease.

  Simonetti GD, Bucher BS, Tschumi S, Lava SA, Bianchetti MG. Simonetti GD, et al. Minerva Pediatr. 2012 Apr;64(2):171-82. Minerva Pediatr. 2012. PMID: 22495191 Review.
• [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].

  Tsuchida H, Kimura K. Tsuchida H, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:617-22. Nihon Rinsho. 2004. PMID: 15171445 Review. Japanese. No abstract available.
• Managing hypertension in patients with chronic kidney disease.

  Zuber K, Gilmartin C, Davis J. Zuber K, et al. JAAPA. 2014 Sep;27(9):37-46. doi: 10.1097/01.JAA.0000453239.92473.41. JAAPA. 2014. PMID: 25148442 Review.
• [Therapy for hypertension associated with kidney disease].

  Suzuki H. Suzuki H. Nihon Naika Gakkai Zasshi. 2003 Feb 10;92(2):264-9. Nihon Naika Gakkai Zasshi. 2003. PMID: 12652731 Review. Japanese. No abstract available.